Pharma Group Holding

pharmagroup-lb.com

Pharma Group is strongly committed to providing its customer base with a diversified portfolio of value-added and reputable brands through innovative marketing and investment strategies for the Levant area: Lebanon, Syria, Jordan and Iraq.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

STEVANATO GROUP AND GERRESHEIMER AG ANNOUNCE COLLABORATION ON THE DEVELOPMENT OF AN INNOVATIVE READY-TO-USE VIAL PLATFORM

Gerresheimer and Stevanato Group | September 08, 2022

news image

Stevanato Group S.p.A. a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, and Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics, announce that they have jointly developed a high-end Ready-To-Use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill® technology. Th...

Read More

CPD AND LEARNING

APPLIED BIOMATH, LLC ANNOUNCES PARTNERSHIP WITH ANTENGENE FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | December 09, 2020

news image

Applied BioMath, the business chief in applying frameworks pharmacology and unthinking demonstrating, reproduction, and examination to de-hazard drug innovative work, today reported a joint effort with Antengene Corporation for the advancement of a frameworks pharmacology displaying in immuno-oncology. Applied BioMath will build up a frameworks pharmacology model for a PDL1/41BB bispecific immunizer, ATG-101, in immuno-oncology signs. The model will be utilized to anticipate clinical beginning a...

Read More

BUSINESS INSIGHTS

LEXISNEXIS® REED TECH™ AND SCHLAFENDER HASE® ALLIANCE PROVIDES MUTUAL CUSTOMER BENEFITS FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES

LexisNexis Reed Tech | April 27, 2022

news image

Reed Technology and Information Services Inc. a leading provider of data management and analytics solutions for the life sciences industry, announced an alliance with Schlafender Hase®, the market leader for intelligent, automated proofreading software and services for regulated industries. Current and prospective customers of both companies can leverage exclusive benefits as part of this new alliance ecosystem. Pharmaceutical labelers who have regulatory deadlines for US FDA can benefit fro...

Read More

NOVARTIS COLLABORATES WITH DNDI FOR VISCERAL LEISHMANIASIS DRUG

Pharmaceutical Technology | February 25, 2020

news image

Swiss pharma giant Novartis and non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) have signed a collaboration and license agreement to jointly develop LXE408 for visceral leishmaniasis. LXE408 is an oral treatment for this parasitic disease, which is transmitted by the bite of a sand fly, and can be life-threatening if left untreated. The drug was initially discovered by Novartis with the financial backing of the Wellcome Trust. DNDi executive direct...

Read More
news image

BUSINESS INSIGHTS

STEVANATO GROUP AND GERRESHEIMER AG ANNOUNCE COLLABORATION ON THE DEVELOPMENT OF AN INNOVATIVE READY-TO-USE VIAL PLATFORM

Gerresheimer and Stevanato Group | September 08, 2022

Stevanato Group S.p.A. a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, and Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics, announce that they have jointly developed a high-end Ready-To-Use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill® technology. Th...

Read More
news image

CPD AND LEARNING

APPLIED BIOMATH, LLC ANNOUNCES PARTNERSHIP WITH ANTENGENE FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | December 09, 2020

Applied BioMath, the business chief in applying frameworks pharmacology and unthinking demonstrating, reproduction, and examination to de-hazard drug innovative work, today reported a joint effort with Antengene Corporation for the advancement of a frameworks pharmacology displaying in immuno-oncology. Applied BioMath will build up a frameworks pharmacology model for a PDL1/41BB bispecific immunizer, ATG-101, in immuno-oncology signs. The model will be utilized to anticipate clinical beginning a...

Read More
news image

BUSINESS INSIGHTS

LEXISNEXIS® REED TECH™ AND SCHLAFENDER HASE® ALLIANCE PROVIDES MUTUAL CUSTOMER BENEFITS FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES

LexisNexis Reed Tech | April 27, 2022

Reed Technology and Information Services Inc. a leading provider of data management and analytics solutions for the life sciences industry, announced an alliance with Schlafender Hase®, the market leader for intelligent, automated proofreading software and services for regulated industries. Current and prospective customers of both companies can leverage exclusive benefits as part of this new alliance ecosystem. Pharmaceutical labelers who have regulatory deadlines for US FDA can benefit fro...

Read More
news image

NOVARTIS COLLABORATES WITH DNDI FOR VISCERAL LEISHMANIASIS DRUG

Pharmaceutical Technology | February 25, 2020

Swiss pharma giant Novartis and non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) have signed a collaboration and license agreement to jointly develop LXE408 for visceral leishmaniasis. LXE408 is an oral treatment for this parasitic disease, which is transmitted by the bite of a sand fly, and can be life-threatening if left untreated. The drug was initially discovered by Novartis with the financial backing of the Wellcome Trust. DNDi executive direct...

Read More